Primary biliary cholangitis with associated Raynaud syndrome treatment outcome: a case report.

Primary biliary cholangitis is an autoimmune liver disease, which is less common than viral hepatitis and fatty liver disease, but in recent decades there has been a steady increase in the PBC occurrence. The development of severe complications, many concomitant pathologies, and frequent lack of response to basic ursodeoxycholic acid (UDCA) therapy requires timely dynamic monitoring of patients with PBC for effective treatment correction.<br /> Here we describe a case presentation of liver cirrhosis development in patient with PBC combined with Raynaud syndrome. Upon disease development, the patient refused to undergo liver biopsy. She was treated with non-conventional treatment regime. Our clinical case showed that the use of budesonide in PBC treatment did not show any promising result and led to rapid liver cirrhosis development.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine of Kazakhstan
Published
2025-09-04
DOI
https://doi.org/10.23950/jcmk/16882
Primary Topic
Liver Diseases and Immunity
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary biliary cholangitis with associated Raynaud syndrome treatment outcome: a case report.

Larissa Kozina, Galiya Shaimardanova, Ainur Doszhan, Nina Tostanovskaya et al.
Journal of Clinical Medicine of Kazakhstan
Liver Diseases and Immunity
article

Primary biliary cholangitis with associated Raynaud syndrome treatment outcome: a case report.

Larissa Kozina, Galiya Shaimardanova, Ainur Doszhan, Nina Tostanovskaya, Gulsara Imambayeva
article en

Abstract

Primary biliary cholangitis is an autoimmune liver disease, which is less common than viral hepatitis and fatty liver disease, but in recent decades there has been a steady increase in the PBC occurrence. The development of severe complications, many concomitant pathologies, and frequent lack of response to basic ursodeoxycholic acid (UDCA) therapy requires timely dynamic monitoring of patients with PBC for effective treatment correction.<br /> Here we describe a case presentation of liver cirrhosis development in patient with PBC combined with Raynaud syndrome. Upon disease development, the patient refused to undergo liver biopsy. She was treated with non-conventional treatment regime. Our clinical case showed that the use of budesonide in PBC treatment did not show any promising result and led to rapid liver cirrhosis development.

Journal of Clinical Medicine of Kazakhstan
National Medical Research Center of Cardiology (RU)
Openalex Percentile: Top 58%
Liver Diseases and Immunity
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Primary biliary cholangitis with associated Raynaud syndrome treatment outcome: a case report. — Larissa Kozina, Galiya Shaimardanova, et al. · Journal of Clinical Medicine of Kazakhstan (2025) | TGRS Research Map | TGRS